Growth Metrics

Align Technology (ALGN) EBITDA Margin (2009 - 2026)

Align Technology (ALGN) reported EBITDA Margin of 13.65% for Q1 2026, up 26.0% year-over-year from 10.83% in Q1 2025, and down 7.95% on a QoQ basis from 14.83% in Q4 2025.

Align Technology (ALGN) has 18 years of EBITDA Margin data on file, last reported at 13.65% in Q1 2026.

  • Quarterly EBITDA Margin rose 26.0% year-over-year to 13.65% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 13.59% (down 110.0% YoY) and the FY2025 annual result came in at 13.53%, down 167.0% from the prior year.
  • EBITDA Margin eased to 13.65% in Q1 2026 per ALGN's latest filing, from 14.83% in the prior quarter.
  • Across five years, EBITDA Margin topped out at 20.35% in Q1 2022 and bottomed at 9.67% in Q3 2025.
  • The 5-year median for EBITDA Margin is 15.45% (2024), against an average of 15.5%.
  • The widest annual swing landed in 2022, when EBITDA Margin plunged 957 bps; it then jumped 543 bps in 2023.
  • Tracing ALGN's EBITDA Margin over 5 years: stood at 12.5% in 2022, then surged by 43 bps to 17.93% in 2023, then decreased by 19 bps to 14.48% in 2024, then increased by 2 bps to 14.83% in 2025, then fell by 8 bps to 13.65% in 2026.
  • Per Business Quant, the three latest ALGN EBITDA Margin figures stand at 13.65% (Q1 2026), 14.83% (Q4 2025), and 9.67% (Q3 2025).

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBITDA Margin (Qtr)
1 Intuitive Surgical 156.17 Bn 151.78 Bn 1.83 Bn 28.86%
2 Becton Dickinson 41.51 Bn 40.49 Bn 2.15 Bn 1.97%
3 Resmed 30.43 Bn 28.77 Bn 890.98 Mn 34.92%
4 West Pharmaceutical Services 22.78 Bn 22.26 Bn 296.40 Mn 20.96%
5 Solventum 13.39 Bn 13.39 Bn 1.10 Bn 4.04%
6 Cooper Companies 12.33 Bn 12.20 Bn 695.20 Mn 19.85%
7 Align Technology 11.65 Bn 10.59 Bn 736.59 Mn 13.65%
8 Baxter International 9.81 Bn 7.77 Bn 891.00 Mn 2.44%
9 Aptargroup 7.39 Bn 7.19 Bn 351.91 Mn 17.48%
10 Repligen 6.39 Bn 5.41 Bn 108.28 Mn -1.77%

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 13.65%
Dec 31, 2025 14.83%
Sep 30, 2025 9.67%
Jun 30, 2025 16.10%
Mar 31, 2025 13.39%
Dec 31, 2024 14.48%
Sep 30, 2024 16.60%
Jun 30, 2024 14.30%
Mar 31, 2024 15.45%
Dec 31, 2023 17.93%
Sep 30, 2023 17.32%
Jun 30, 2023 17.16%
Mar 31, 2023 14.16%
Dec 31, 2022 12.50%
Sep 30, 2022 16.14%
Jun 30, 2022 19.41%
Mar 31, 2022 20.35%
Dec 31, 2021 21.42%
Sep 30, 2021 25.71%
Jun 30, 2021 26.60%
Mar 31, 2021 25.20%
Dec 31, 2020 24.45%
Sep 30, 2020 24.12%
Jun 30, 2020 -20.72%
Mar 31, 2020 12.69%
Dec 31, 2019 24.91%
Sep 30, 2019 20.94%
Jun 30, 2019 29.38%
Mar 31, 2019 15.97%
Dec 31, 2018 22.56%
Sep 30, 2018 24.78%
Jun 30, 2018 25.02%
Mar 31, 2018 22.47%
Dec 31, 2017 127.45%
Sep 30, 2017 25.63%
Jun 30, 2017 23.44%
Mar 31, 2017 19.87%
Dec 31, 2016 134.06%
Sep 30, 2016 22.28%
Jun 30, 2016 24.18%
Mar 31, 2016 22.34%
Dec 31, 2015 25.77%
Sep 30, 2015 18.32%
Jun 30, 2015 20.20%
Mar 31, 2015 24.70%
Dec 31, 2014 25.93%
Sep 30, 2014 27.15%
Jun 30, 2014 25.31%
Mar 31, 2014 23.14%
Dec 31, 2013 29.68%
Sep 30, 2013 25.21%
Jun 30, 2013 23.13%
Mar 31, 2013 -24.79%
Dec 31, 2012 11.95%
Sep 30, 2012 3.30%
Jun 30, 2012 24.73%
Mar 31, 2012 20.73%
Dec 31, 2011 20.50%
Sep 30, 2011 20.90%
Jun 30, 2011 13.82%
Mar 31, 2011 20.05%
Dec 31, 2010 15.90%
Sep 30, 2010 22.85%
Jun 30, 2010 41.91%
Mar 31, 2010 22.97%
Dec 31, 2009 14.71%
Sep 30, 2009 -75.94%
Jun 30, 2009 8.19%